Stay updated on Nivolumab for Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab for Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedRelated topics Prostate cancer and MedlinePlus Genetics were removed from the page's related resources, reducing navigational options for related information. This change does not affect the core trial content or how to participate.SummaryDifference0.6%

- Check10 days agoChange DetectedThe related topics section now includes Prostate cancer and MedlinePlus Genetics for additional navigation context. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoChange DetectedAdded MedlinePlus Genetics topic: Prostate cancer.SummaryDifference0.2%

- Check24 days agoChange Detected- Removed MedlinePlus Genetics topic related to Prostate cancer from the page. This reduces available information on that specific genetic topic.SummaryDifference0.2%

- Check32 days agoChange DetectedSignificant changes: the page now states a funding lapse and current operating status of the NIH Clinical Center, and updates the software version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check39 days agoChange DetectedAdded MedlinePlus Genetics topic on Prostate cancer and updated the revision from v3.0.2 to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to Nivolumab for Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.